C

COMPASS Pathways Plc
D

CMPS

13.440
USD
0.14
(1.05%)
قبل الجلسة·13.240USD-0.200(-1.49%)
حجم التداول
44,898
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
1,861,128,488
أصول ذات صلة المقالات
المزيد

العنوان: COMPASS Pathways Plc

القطاع: الرعاية الصحية
الصناعة: Medical Care Facilities
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.